Nuveen’s CervoMed CRVO Stock Holding History

Nuveen’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34,099	Closed	-$312K	–	3298
2025 Q1	$312K	Sell	34,099 -7,470	-18%	-$28.4K	﹤0.01%	3031
2024 Q4	$97.3K	Buy	41,569 +22,104	+114%	+$215K	﹤0.01%	3293
2024 Q3	$284K	Buy	+19,465	New	+$302K	﹤0.01%	3157

Other funds holding CRVO

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return

AAS

Avantax Advisory Services Dallas, Texas $18.2B AUM 15.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen's CRVO Position: Q2 2025 in Review

Nuveen sold out of CervoMed (CRVO) in Q2 2025, closing a stake of 34,099 shares — an estimated $312K sold.

Nuveen first reported a position in CRVO in Q3 2024 and held it in 3 quarters. The position peaked at $312K in Q1 2025. 45 funds tracked by Wall St. Rank hold CRVO as of Q2 2025.

Nuveen reported no remaining CervoMed position as of Q2 2025 after selling out during the quarter.
Nuveen sold 34,099 CervoMed shares in Q2 2025, an estimated $312K.
Nuveen first reported a position in CervoMed in Q3 2024 and held it in 3 quarters.
Nuveen's CervoMed position peaked at $312K in Q1 2025.
45 funds tracked by Wall St. Rank held CervoMed as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.